Related Experiment Video
Updated: Feb 4, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Hepatic copper concentrations in 546 dogs (1982-2015)
Jaimie M Strickland1, John P Buchweitz1, Rebecca C Smedley2
1From the Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, 48824.
Hepatic copper concentrations ([Cu]H) have significantly increased in dogs over 34 years, contributing to copper-associated hepatitis (CAH) in both predisposed and non-predisposed breeds.
Area of Science:
- Veterinary Pathology
- Canine Hepatology
- Toxicology
Background:
- Copper-associated hepatitis (CAH) is increasingly diagnosed in dogs.
- Hereditary defects in copper metabolism may be worsened by environmental copper.
- Limited epidemiological data exists on canine hepatic copper ([Cu]H) trends.
Purpose of the Study:
- To investigate temporal trends in canine hepatic copper concentrations ([Cu]H).
- To explore associations between [Cu]H, breed, demographics, and hepatitis over 34 years.
Main Methods:
- Retrospective analysis of 546 archived canine liver specimens.
- Classification by breed (predisposed vs. non-predisposed), time period, and hepatitis presence.
- Quantification of hepatic copper ([Cu]H) using inductively coupled plasma mass spectrometry.
Main Results:
- Median [Cu]H increased significantly from 1982-1988 to 2009-2015 in both predisposed and non-predisposed breeds.
- The proportion of dogs with elevated [Cu]H (>300 μg/g) rose substantially in both groups.
- Median [Cu]H in dogs with hepatitis tripled over the study period.
Conclusions:
- Rising hepatic copper levels correlate with increased CAH diagnoses in dogs.
- Elevated copper concentrations impact both predisposed and non-predisposed breeds.
- Environmental factors likely contribute to the observed increase in canine CAH.
Related Concept Videos
Concentration Cells
Consider the following voltaic cell:
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Solution Concentration and Dilution
Stress Concentrations
The stress...
Stress Concentrations

